Health experts of the country have pointed out that the benefits of the drug outweigh the potential risks it may have in the case of high-risk patients
The primary objective of the ongoing trial is to determine whether ambrisentan can prevent the progression to respiratory failure and reduce the need for mechanical ventilation, among others
The tablets are indicated for the treatment of pulmonary arterial hypertension
Gavreto is the first and only precision medicine approved in the EU for first-line treatment of people with RET fusion-positive advanced NSCLC
This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one
Incidences of Non-alcoholic Fatty Liver Disease (NAFLD) have been rising exponentially worldwide and are associated with co-morbidities including obesity, diabetes, hypertension and metabolic disorders
India reports 18 lakh stroke cases a year with 25 per cent patients below the age of 50
Alnylam is the latest partner in the Medicines Manufacturing Innovation Centre’s third Grand Challenge project, which aims to revolutionise the manufacturing process for oligonucleotide therapies
The acquisition complements and strengthens Merck’s cardiovascular pipeline
The consultations are virtual and they have launched the Diabetes Reversal Programme to address the issue
Subscribe To Our Newsletter & Stay Updated
